NCT04869488 2025-01-24
A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
Clinical Trials
5 trialsNCT04458311 2024-04-25
ACTIon
Institute of Cancer Research, United Kingdom
Phase 1/2 Terminated
NCT04179396 2023-06-29
RAMP
pharmaand GmbH
Phase 1 Completed
NCT02426333 2019-09-13
OPTIMUM
Radboud University Medical Center
Completed
NCT04056754 2019-08-14
Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Completed